MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.

MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.
复制标题

DOI:
10.1080/21655979.2021.1871817
复制
发表时间:
2021-12
期刊:
影响因子:
4.9
通讯作者:
Jie Y
Jie Y
中科院分区:
生物学2区
文献类型:
--
作者:
Cai L;Ye L;Hu X;He W;Zhuang D;Guo Q;Shu K;Jie Y

文献摘要

参考文献

被引文献

相似文献

已有研究报道miR-330- 3 p参与多种肿瘤的发生发展,但其在卵巢癌(OC)中的作用尚不清楚。本研究旨在探讨miR-330- 3 p在OC中的表达模式及其功能。采用RT-qPCR检测miR-330- 3 p在OC组织和细胞系中的表达水平。CCK-8法检测OC细胞的增殖能力,transwell法检测OC细胞的迁移能力和侵袭能力。采用生物信息学分析和荧光素酶报告基因分析方法分析miR-330- 3 p与RIPK 4的靶向结合位点。结果显示,miR-330- 3 p在OC组织和细胞系中表达显著下调。过表达miR-330- 3 p可抑制OC细胞的增殖、迁移和侵袭。从机制上讲,双荧光素酶报告的测定显示RIPK 4是miR-330- 3 p的靶基因。此外,拯救实验显示miR-330- 3 p通过靶向RIPK 4抑制OC细胞的增殖、迁移和侵袭。总之,我们的研究结果表明,miR-330- 3 p通过靶向RIPK 4抑制OC的进展。我们的研究结果提示miR-330- 3 p/RIPK 4轴可能成为OC治疗的新靶点。
Previous studies reported that miR-330-3p was involved in the progression of several cancers, but the potential roles of miR-330-3p in ovarian cancer (OC) were unclear. In the current study, we aimed to explore the expression pattern and functions of miR-330-3p in OC. The expression level of miR-330-3p in OC tissues and cell lines was detected using RT-qPCR. The proliferation, migration and invasion of OC cells were detected using CCK-8 assay and transwell assay, respectively. Bioinformatics analysis and luciferase reporter assay were used to analyze the targeted binding site of miR-330-3p and RIPK4. The results showed that miR-330-3p was significantly downregulated in OC tissues and cell lines. Overexpression of miR-330-3p inhibited the proliferation, migration and invasion of OC cells. Mechanistically, a dual-luciferase reported assay showed that RIPK4 is a target gene of miR-330-3p. Furthermore, rescue experiments revealed that miR-330-3p suppressed the proliferation, migration and invasion of OC cells by targeting RIPK4. In summary, our findings indicated that miR-330-3p suppressed the progression of OC by targeting RIPK4. Our results indicated that miR-330-3p/RIPK4 axis might act as a novel therapeutic target for OC treatment.
DOI: 10.1097/mcp.0b013e3283566721
发表时间: 2012-09
影响因子: 3.3
作者:
Kage H;Borok Z
通讯作者: Borok Z
DOI: 10.1093/nar/gkx1141
发表时间: 2018-01-04
影响因子: 14.9
作者:
Karagkouni D;Paraskevopoulou MD;Chatzopoulos S;Vlachos IS;Tastsoglou S;Kanellos I;Papadimitriou D;Kavakiotis I;Maniou S;Skoufos G;Vergoulis T;Dalamagas T;Hatzigeorgiou AG
通讯作者: Hatzigeorgiou AG
DOI: 10.1007/978-1-61779-037-9_3
发表时间: 2011-01-01
期刊: ANTIVIRAL RNAI: CONCEPTS, METHODS, AND APPLICATIONS
影响因子: --
作者:
Plaisance-Bonstaff, Karlie;Renne, Rolf
通讯作者: Renne, Rolf
DOI: 10.3892/ol.2019.10280
发表时间: 2019-07-01
期刊: ONCOLOGY LETTERS
影响因子: 2.9
作者:
Jin, Zhe;Jia, Baoxing;Liu, Yahui
通讯作者: Liu, Yahui
DOI: 10.1074/jbc.m004771200
发表时间: 2000-11-17
影响因子: 4.8
作者:
Bähr, C;Rohwer, A;Gschwendt, M
通讯作者: Gschwendt, M